Skip to main content
Equibles
PCVX logo

PCVX · Vaxcyte, Inc.

Track PCVX — free

Use PCVX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about PCVX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$58.07 -0.79 (-1.34%) At close · Aug 14
Market Cap
$8.64B
Shares
148.81M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding PCVX

429 fund positions
Fund Balance Value % of Fund Open
VANGUARD TOTAL STOCK MARKET INDEX FUND 4,585,888 $266,485,952 0.01%
VANGUARD SMALL-CAP INDEX FUND 3,318,448 $192,835,013 0.12%
iShares Russell 2000 ETF 3,035,437 $176,389,244 0.25%
Strategic Advisers Fidelity U.S. Total Stock Fund 3,034,105 $155,952,997 0.06%
VANGUARD HEALTH CARE FUND 2,667,349 $152,679,057 0.41%
T. Rowe Price Capital Appreciation Fund 2,539,929 $147,595,274 0.22%
Janus Henderson Enterprise Fund 2,269,870 $131,902,146 0.65%
Janus Henderson Forty Fund 2,241,120 $130,231,483 0.63%
VANGUARD SMALL-CAP GROWTH INDEX FUND 1,858,643 $108,005,745 0.28%
T. Rowe Price Mid-Cap Growth Fund, Inc. 1,491,100 $86,647,821 0.38%
State Street(R) SPDR(R) S&P(R) Biotech ETF 1,472,715 $85,579,469 1.15%
VANGUARD EXTENDED MARKET INDEX FUND 1,431,800 $83,201,898 0.10%
T. Rowe Price Small-Cap Value Fund, Inc. 1,369,591 $79,586,933 0.86%
Fidelity Advisor Growth Opportunities Fund 1,477,243 $75,930,290 0.22%
Fidelity Small Cap Index Fund 1,228,567 $70,323,175 0.22%
iShares Russell 2000 Value ETF 1,067,186 $62,014,178 0.50%
iShares Biotechnology ETF 1,045,695 $60,765,336 0.75%
Select Health Care Portfolio 1,160,000 $59,624,000 1.03%
Janus Henderson Global Life Sciences Fund 971,737 $56,467,637 1.09%
Janus Henderson Research Fund 873,455 $50,756,470 0.20%
Eventide Healthcare & Life Sciences Fund 827,521 $48,087,245 3.03%
SMALLCAP World Fund Inc 814,688 $47,341,520 0.06%
Harbor Small Cap Growth Fund 824,015 $47,166,619 1.82%
Fidelity Advisor Biotechnology Fund 763,629 $43,710,124 2.30%
Fidelity Stock Selector Small Cap Fund 735,811 $42,117,822 0.61%
T. Rowe Price Small-Cap Stock Fund, Inc. 692,942 $40,266,860 0.50%
Janus Henderson Contrarian Fund 669,842 $38,924,519 0.91%
Janus Henderson Triton Fund 665,340 $38,662,907 0.75%
abrdn Healthcare Investors 607,065 $35,276,547 3.10%
JNL/T. Rowe Price Capital Appreciation Fund 582,211 $33,832,281 0.24%
Fidelity Growth Company Fund 657,933 $33,817,756 0.03%
Fidelity Extended Market Index Fund 657,078 $33,773,809 0.08%
VANGUARD RUSSELL 2000 INDEX FUND 638,244 $32,805,742 0.19%
Schwab U.S. Small-Cap ETF 617,889 $31,759,495 0.14%
Fidelity Advisor Health Care Fund 540,000 $30,909,600 1.07%
Eventide Gilead Fund 514,957 $29,924,151 1.12%
Fidelity Series Small Cap Opportunities Fund 517,798 $29,638,758 0.59%
Janus Henderson Global Select Fund 503,822 $29,277,096 0.96%
T. Rowe Price Capital Appreciation Equity ETF 469,736 $27,296,359 0.44%
Janus Henderson Venture Fund 460,764 $26,774,996 0.87%
Fidelity Series Large Cap Stock Fund 432,100 $25,109,331 0.10%
PGIM Jennison Health Sciences Fund 479,492 $24,645,889 1.77%
Select Biotechnology Portfolio 474,755 $24,402,407 0.46%
VANGUARD EXPLORER FUND 413,100 $23,645,844 0.11%
Victory Pioneer Select Mid Cap Growth Fund 440,429 $22,638,051 1.19%
T. Rowe Price Institutional Small-Cap Stock Fund 378,076 $21,969,996 0.51%
Fidelity Small Cap Value Fund 361,700 $20,703,708 0.41%
PGIM Jennison Small Company Fund 331,960 $19,290,196 0.61%
Fidelity U.S. Equity Central Fund 328,000 $19,060,080 0.09%
T. Rowe Price Health Sciences Fund, Inc. 314,645 $18,284,021 0.17%
Showing 1–50 of 429 positions
Key facts CIK 1649094 CUSIP 92243G108 13F (30d) 321 filings 316 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)